Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.890
+0.030 (3.49%)
At close: Nov 4, 2024, 4:00 PM
0.875
-0.015 (-1.71%)
After-hours: Nov 4, 2024, 7:46 PM EST
Hoth Therapeutics Employees
As of December 31, 2023, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,487,370
Market Cap
6.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Biofrontera | 85 |
Mainz Biomed | 71 |
Biomerica | 64 |
Intelligent Bio Solutions | 50 |
Windtree Therapeutics | 20 |
Purple Biotech | 20 |
Portage Biotech | 7 |
HOTH News
- 6 days ago - Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study - PRNewsWire
- 20 days ago - Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway - PRNewsWire
- 6 weeks ago - Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ - PRNewsWire
- 2 months ago - Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial - PRNewsWire
- 2 months ago - Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001 - PRNewsWire
- 2 months ago - Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic - PRNewsWire
- 3 months ago - Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment - PRNewsWire
- 3 months ago - Hoth Therapeutics Expands Clinical Trial for Cancer Patients - PRNewsWire